FierceBiotech Nexavar in combination with gemcitabine /cisplatin is not recommended in patients with squamous cell lung cancer. The safety and effectiveness of Nexavar has not been established in patients with non-small cell lung cancer. Nexavar can prolong the QT ... and more »
Waterloo Record Marchese Hospital Solutions prepared the drug-and-saline mixture that was supplied to four hospitals in Ontario and one in New Brunswick. The extra salin...
Canada NewsWire (press release) The trial evaluated afatinib, an irreversible ErbB Family blocker, (n=242) compared to standard chemotherapy ( gemcitabine and cisplatin...
PR Newswire (press release) In this Phase 1b study, 28 stage IV pancreatic ductal adenocarcinoma patients were treated with PEGPH20 in combination with gemcitabine . Th...
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
EON: Enhanced Online News (press release) The program is currently in two Phase 1b/2 proof-of-concept trials in cancer indications: 1) the Phase1b/2 “ALPINE” trial (Antibody therapy in first-Line Pancreatic cancer Investigating anti-Notch Efficacy and safety) is testing Anti-Notch2/3 with ... and more »
Seeking Alpha And this is from a Phase 1b study, it will be a single-arm study with PEGPH20 in gemcitabine , so there will be some news out tomorrow on that as those abstracts become available. And we also announced earlier this month that we started a Phase 2 study ... and more »
Sacramento Bee Nexavar in combination with gemcitabine /cisplatin is not recommended in patients with squamous cell lung cancer. The safety and effectiveness of Nexavar has not been established in patients with non-small cell lung cancer. Nexavar can prolong the QT ... and more »
Healio Capecitabine demonstrated encouraging efficacy and toxicity outcomes compared with gemcitabine in a cohort of patients with locally advanced pancreatic cancer, according to phase 2 results of the SCALOP trial. Researchers conducted the open-label, ...
